| Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study H Sorbye, S Welin, SW Langer, LW Vestermark, N Holt, P Osterlund, ... Annals of Oncology 24 (1), 152-160, 2012 | 1038 | 2012 |
| 99 RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER DISEASE: A NATIONWIDE POPULATION-BASED CASE-CONTROL STUDY KK Søgaard, E Horváth-Puhó, H Grønbæk, P Jepsen, H Vilstrup, ... Journal of Hepatology 50, S41, 2009 | 492 | 2009 |
| Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case–control study KK Søgaard, E Horváth-Puhó, H Grønbæk, P Jepsen, H Vilstrup, ... The American journal of gastroenterology 104 (1), 96-101, 2009 | 492 | 2009 |
| Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies S Rinaldi, R Cleveland, T Norat, C Biessy, S Rohrmann, J Linseisen, ... International journal of cancer 126 (7), 1702-1715, 2010 | 308 | 2010 |
| Portal vein thrombosis; risk factors, clinical presentation and treatment KK Sogaard, LB Astrup, H Vilstrup, H Gronbaek BMC gastroenterology 7 (1), 34, 2007 | 294 | 2007 |
| Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition M Jenab, E Riboli, RJ Cleveland, T Norat, S Rinaldi, A Nieters, C Biessy, ... International journal of cancer 121 (2), 368-376, 2007 | 225 | 2007 |
| Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women T Norat, L Dossus, S Rinaldi, K Overvad, H Grønbæk, A Tjønneland, ... European journal of clinical nutrition 61 (1), 91-98, 2007 | 210 | 2007 |
| Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C K Kazankov, F Barrera, HJ Møller, BM Bibby, H Vilstrup, J George, ... Hepatology 60 (2), 521-530, 2014 | 192 | 2014 |
| The renal expression of transforming growth factor-β isoforms and their receptors in acute and chronic experimental diabetes in rats C Hill, A Flyvbjerg, H Grønbaek, J Petrik, DJ Hill, CR Thomas, ... Endocrinology 141 (3), 1196-1208, 2000 | 188 | 2000 |
| The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition FL Crowe, TJ Key, NE Allen, PN Appleby, A Roddam, K Overvad, ... Cancer Epidemiology and Prevention Biomarkers 18 (5), 1333-1340, 2009 | 183 | 2009 |
| Soluble CD163 from activated macrophages predicts mortality in acute liver failure HJ Møller, H Grønbæk, FV Schiødt, P Holland-Fischer, M Schilsky, ... Journal of hepatology 47 (5), 671-676, 2007 | 178 | 2007 |
| Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis H Grønbaek, TD Sandahl, C Mortensen, H Vilstrup, HJ Møller, S Møller Alimentary pharmacology & therapeutics 36 (2), 173-180, 2012 | 172 | 2012 |
| Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS P Holland-Fischer, H Grønbæk, TD Sandahl, SK Moestrup, O Riggio, ... Gut 60 (10), 1389-1393, 2011 | 139 | 2011 |
| Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms ET Janson, H Sorbye, S Welin, B Federspiel, H Grønbæk, P Hellman, ... Acta Oncologica 53 (10), 1284-1297, 2014 | 136 | 2014 |
| Peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in Switzerland AK Pfeifer, T Gregersen, H Grønbæk, CP Hansen, J Müller-Brand, ... Neuroendocrinology 93 (3), 189-196, 2011 | 135 | 2011 |
| Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and … NE Allen, TJ Key, PN Appleby, RC Travis, AW Roddam, S Rinaldi, ... Cancer Epidemiology and Prevention Biomarkers 16 (6), 1121-1127, 2007 | 134 | 2007 |
| Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease S Heebøll, M Kreuzfeldt, S Hamilton-Dutoit, M Kjær Poulsen, ... Scandinavian journal of gastroenterology 51 (4), 456-464, 2016 | 133 | 2016 |
| Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label … P Ferolla, MP Brizzi, T Meyer, W Mansoor, J Mazieres, C Do Cao, H Léna, ... The Lancet Oncology 18 (12), 1652-1664, 2017 | 127 | 2017 |
| Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition. AJ Price, NE Allen, PN Appleby, FL Crowe, RC Travis, SJ Tipper, ... Cancer Epidemiology and Prevention Biomarkers, cebp. 0481.2012, 2012 | 122 | 2012 |
| MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C K Thabet, A Asimakopoulos, M Shojaei, M Romero-Gomez, A Mangia, ... Nature communications 7, 12757, 2016 | 121 | 2016 |
